System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Daniel Azoulay is an expert in Surgery at Hôpital Paul-Brousse (France). As of October 2026, ScienceLeadR ranks Daniel Azoulay in the top 1% of experts worldwide for Liver Transplantation, Tissue Transplantation and Liver Neoplasms. Daniel Azoulay has authored 734 publications, the most recent in 2026, and is an investigator in 4 clinical trials, 1 of them ongoing. SLR score: 2,036 (community average: 125). How the SLR is computed.

LeadR Profile

Daniel Azoulay Hôpital Paul-Brousse France
2 036 ScienceLeadR Reputation 2036

Unlock

Register Login
Network Map

Surgery

Subspecialties: Hepatology - Transplantation - Oncology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 1990 - 2026
Source: PubMed

Centre Hépato-Biliaire

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 734

Citations

Citations: 34 371 1st author: 88 Last author: 200 Unique author: 3

Main journals

HPB (Oxford) 66
J Hepatol 61
Ann Surg 54
Transplantation 34
Liver Transpl 22

Best Journals

J Hepatol 7
J Clin Oncol 3
Ann Intern Med 1

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Predictors of morbidity and oncological benefit after liver resection with vascular reconstruction: international collaborative study from expert centres.
PMID 42803787 — mortality, carcinoma, hepatocellular, hepatic veins, portal vein, liver, vena cava, inferior, operative time, transplants, morbidity, veins, cholangiocarcinoma, extrahepatic cholangiocarcinoma		BJS Open20260
Is Cytoreductive surgery for unresectable colorectal liver metastases able to improve patient outcome? Results of a pilot prospective study.
PMID 42561547 — pilots, cytoreduction surgical procedures, drug therapy, liver, hepatectomy, neoplasm metastasis, prospective studies, chemotherapy		Cancer Treat Rev20260
Right (H145678) and Left (H123458) 6-Segmentectomies for Malignant Liver Tumors: A Retrospective Analysis of 237 Cases Using Contemporary Surgery Quality Indicators.
PMID 42522084 — neoplasms, mastectomy, segmental, liver, general surgery, cholangiocarcinoma, survival rate		Ann Surg20260
Everolimus and de novo malignancies after liver transplantation: a Nationwide Emulated Trial Using Real-World Data.
PMID 42413767 — liver transplantation, incidence, neoplasms, tacrolimus, liver, everolimus, transplants, research, immunosuppression therapy, transplantation		JHEP Rep20260
ASO Visual Abstract: Is R1 Extended Liver Resection for Locally Advanced Intrahepatic Cholangiocarcinoma Justified? Nodal Status Not Margin Drives Prognosis.
PMID 42406213 — liver, prognosis, cholangiocarcinoma, intrahepatic cholangiocarcinoma		Ann Surg Oncol20260

Clinical Studies 4

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

N/A 3
Phase 2 1

By status:

Completed 2
Not yet recruiting 1
Unknown 1

By type:

Interventional 3
Observational 1

By Monocentric/Multicentric:

monocentric 3
multicentric2to4 0
multicentric5to9 0
multicentricup10 1

Main Topics

Cohort/Consortium Investigators 8

Ongoing Clinical Trials

Ongoing trial started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Resection And Partial LIver Transplantation With Delayed Hepatectomy for Hepatocellular Carcinoma
NCT05971628 — liver transplantation, carcinoma, hepatocellular, liver, hepatectomy, transplantation, carcinoma		N/ANot yet recruiting2023

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS